Organization (Hospital)
Northwestern Medicine
ClinicalTrials.gov lists Northwestern Medicine as lead sponsor of 11 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Northwestern Medicine and 1 company grouped under it: 11 lead-sponsored trials (5 its own, 6 in the grouped companies) and 2 legal-entity registrations (1 its own, 1 in the grouped companies).
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Companies grouped under this page (1)
| Company | Lead trials | Legal entities |
|---|---|---|
| Central DuPage Hospital | 6 | 1 |
Disease areas (124)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Breast Neoplasms | 7 |
| Lung Neoplasms | 5 |
| Lymphoma | 5 |
| Head and Neck Neoplasms | 4 |
| Inflammation | 4 |
Showing 5 of 124 disease areas.
Trials by start year as sponsor or collaborator (9)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 6 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 2 |
| 2020 | 4 |
| 2019 | 1 |
| 2018 | 1 |
| 2015 | 1 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 2 hit target (n=2) | 1 of 2 on time (n=2) |
Journals published in (201)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Clinical orthopaedics and related research | 14 |
| The Journal of arthroplasty | 10 |
| Transplantation | 10 |
| Plastic and reconstructive surgery | 8 |
| The New England journal of medicine | 8 |
Showing 5 of 201 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 5 | 5 | 2025-12-23 |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| NAI | 6 |
Organization relationships (45)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Government of the United States of America | Co sponsors trial with | 5 |
| University of California System | Co sponsors trial with | 4 |
| Shirley Ryan AbilityLab | Co sponsors trial with | 2 |
| Columbia University | Co sponsors trial with | 2 |
| University of Virginia | Co sponsors trial with | 2 |
Showing 5 of 45 relationships.
Latest dated events (117)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-09-08 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-05-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 117 events.
CLIA clinical laboratory certificates (1)
| Lab | Certificate | Status |
|---|---|---|
| NORTHWESTERN MEDICINE (SYCAMORE ENT/ALLERGY) | Certificate of waiver | Active |
Biomarker capability evidence (4)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| NF2 | Trial collaborator | Named in trial inclusion criteria |
| SLC50A1 | Trial collaborator | Named in trial inclusion criteria |
| NF2 | Trial collaborator | Mentioned in trial text |
| SLC50A1 | Trial collaborator | Mentioned in trial text |
Biomarkers this organization publishes on (574)
Shown in this order: most publications first.
Showing 5 of 574 biomarkers.
On Scientist.com
Northwestern Medicine is listed as a research supplier in the Scientist.com network.
The cancer center was first established at Northwestern University in 1974. In 1991 the center was dedicated as the Robert H. Lurie Cancer Center of Northwestern University through a gift of endowment from Ann and Robert H. Lurie. The center's title was modified in 1997, when the National Cancer Institute (NCI) awarded the Lurie Cancer Center the highly competitive "comprehensive" designation — reflecting the center's dedication to the highest standards of cancer research, patient care, education, and community outreach. Today, the Lurie Cancer Center is one of only 41 NCI-designated...
Show the full description
The cancer center was first established at Northwestern University in 1974. In 1991 the center was dedicated as the Robert H. Lurie Cancer Center of Northwestern University through a gift of endowment from Ann and Robert H. Lurie. The center's title was modified in 1997, when the National Cancer Institute (NCI) awarded the Lurie Cancer Center the highly competitive "comprehensive" designation — reflecting the center's dedication to the highest standards of cancer research, patient care, education, and community outreach.
Today, the Lurie Cancer Center is one of only 41 NCI-designated "Comprehensive" cancer centers in the nation. In addition, the Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 25 of the world's leading cancer centers dedicated to improving the quality and effectiveness of care provided to patients with cancer and part of the Big Ten Cancer Research Consortium, a network of academic institutions working together on highly translational clinical trials using the expertise of Big Ten universities.
- Website
- cancer.northwestern.edu
Not on this page
Checked, with nothing recorded for this organization: active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, and workforce and board diversity, as filed.
Work with Northeastern University - Robert H. Lurie Comprehensive Cancer Center on Scientist.com
For prices, more details, or to contact Northeastern University - Robert H. Lurie Comprehensive Cancer Center, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.